<DOC>
	<DOCNO>NCT01815268</DOCNO>
	<brief_summary>The purpose study prospectively evaluate relative effectiveness high dose influenza vaccine prevent influenza mortality , hospitalization , functional decline nursing home population U.S. , compare standard dose trivalent seasonal influenza vaccine .</brief_summary>
	<brief_title>High-Dose Influenza Vaccine Nursing Homes</brief_title>
	<detailed_description>SUMMARY : This nationally representative study sample estimate 6782 Medicare-certified nursing home co-located within 50 mile 122 city report Center Disease Control Prevention ( CDC ) weekly influenza surveillance . In total , 1000 facility enrol random assignment either : 1 ) license high dose ( HD ) trivalent influenza vaccine ( High-Dose Fluzone [ HD vaccine ] ) , 2 ) standard dose ( SD ) trivalent influenza vaccine ( Fluzone [ SD vaccine ] ) resident . Additionally , half facility receive free SD vaccine staff remain facility practice usual care ( free vaccine ) staff . BACKGROUND : Influenza pneumonia ( P &amp; I ) lead infectious cause hospitalization mortality community-dwelling older adult resident long-term custodial care facility nurse home ( NH ) , produce substantial annual health care cost . The elderly incur 90 % disease burden NH resident especially vulnerable give immune senescence , multimorbidity , close living quarter . While hospitalization rate NH resident vary considerably facility , occur sixteen week peak influenza activity annually . Influenza vaccination , mainstay prevention , recommend U.S. individual six month age old . Vaccination associate reduce rate stroke , heart attack , hospitalization , death non-institutional older adult population . However , benefit influenza vaccine elderly general question , salient concern frail elderly , NH resident . Influenza vaccination rate vary substantially nursing home . Influenza vaccine response decline advance age , indicate need good vaccine . OBJECTIVES : The primary objective estimate difference all-cause hospitalization rate influenza season experience long-stay nursing home resident , facility use HD vaccine vs. SD vaccine . The secondary objective estimate difference likelihood Activities Daily Living ( ADL ) functional decline mortality rate study nursing home .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Longterm care facility within 50 mile one 122 city serve CDC surveillance site Facilities already systematically administer HD vaccine resident Facilities fewer 50 longstay resident Hospitalbased facility Facilities 20 % population age 65 Facilities submit Minimum Data Set ( MDS ) data</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Influenza</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Flu Vaccine</keyword>
	<keyword>Fluzone</keyword>
	<keyword>HD Fluzone</keyword>
	<keyword>Nursing Home</keyword>
	<keyword>Hospitalization</keyword>
	<keyword>Mortality</keyword>
	<keyword>Health Care worker vaccination</keyword>
	<keyword>ADL decline</keyword>
	<keyword>Effectiveness</keyword>
	<keyword>Elderly</keyword>
	<keyword>Morbidity</keyword>
	<keyword>Nursing Home resident</keyword>
	<keyword>Frail</keyword>
	<keyword>Institutionalized</keyword>
	<keyword>Epidemiology</keyword>
	<keyword>CDC</keyword>
	<keyword>US</keyword>
	<keyword>city</keyword>
</DOC>